A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3)
Clinical trial NCT00420784 · COMPLETED
Trial details
- NCT number
- NCT00420784
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2008-12-01
- Enrollment
- 465
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.